Pharmacy DSCSA Requirements

Receive and store transaction data for a minimum of six years.
Be sure the pharmacy can quickly retrieve the data if requested.
Only except prescription drugs if they are accompanied by complete and accurate product tracing documentation.

The pharmacy should engage in business only with licensed or registered suppliers.

The pharmacy must have a method to identify, quarantine, investigate, and if necessary, report suspect and/or illegitimate product.

Physically inspect the product to ensure it has a product identifier, also known as a 2D barcode.

Make sure the pharmacy understands the importance of DSCSA and their part in protecting the US Pharmaceutical Supply Chain and more importantly, the patients.

Have a policy detailing how the pharmacy will meet the requirements of the DSCSA and ensure the staff is fully trained in the process.

Also known as Enhanced Drug Distribution Security (EDDS)

All transaction data traveling between entities in the supply chain must be exchanged in an electronic format.
Transaction information must include the unique product identifier down to the lowest saleable unit for every prescription drug product that is covered under DSCSA
Saleable returns must be accompanied by transaction information and transaction statement.

The pharmacy is required to have a system in place to verify suspect product in which a message is sent to the manufacturer to verify the lot and serial number on the product in question is legit.
With EDDS, transaction history will no longer be part of the required transaction data therefore the pharmacy must have a method to trace the product from the pharmacy all the way back to the manufacturer.
The pharmacy may be required to perform product tracing at the request of an auditor or other industry regulator and must do so within 24 hours.

DSCSA Requirements for Pharmacy Dispensers Explained

The Drug Supply Chain Security Act, or DSCSA, is a federal law designed to strengthen the security of the U.S. prescription drug supply chain and improve patient safety. The law requires trading partners, including manufacturers, wholesale distributors, repackagers, third-party logistics providers, and dispensers, to identify and trace certain prescription drugs as they move through the supply chain.

For pharmacy dispensers, DSCSA brings important changes to how prescription drugs are received, verified, documented, and investigated. The goal is to create an electronic, interoperable system that allows prescription drugs to be traced at the package level, helping prevent illegitimate, counterfeit, or potentially harmful products from reaching patients.

As the pharmaceutical supply chain moves toward full electronic data exchange, pharmacies must be prepared to manage DSCSA documentation, respond to tracing requests, verify product information, and maintain procedures for handling suspect or illegitimate products.

Dispensers need a reliable system that supports DSCSA compliance, including the ability to:

Receive and maintain required transaction information
Verify prescription drug products when needed
Trace products through the supply chain when requested
Confirm that ordered pharmaceutical products have been received
Identify, investigate, and quarantine suspect products
Maintain documentation for audits, payor reviews, and compliance requests

For many pharmacies, DSCSA compliance can feel complex because it affects daily receiving, inventory, documentation, and verification workflows. InfiniTrak helps make this process easier by giving pharmacy dispensers a secure, reliable platform to manage drug traceability, product verification, documentation, and compliance workflows in one place.

How Does DSCSA Impact Pharmacies?

The biggest impact of DSCSA on pharmacies is the day-to-day handling of prescription drugs, especially during the receiving process.

Pharmacies need procedures that allow their teams to receive products efficiently while still meeting DSCSA requirements. This means under DSCSA pharmacies must:

Check products for required product identifiers
Confirm that transaction data is available for prescription drug products received
Match product data such as NDC, description, GTIN, lot number, expiration date, and serial number where applicable
Inspect products for signs of suspect or illegitimate product
Quarantine products that require additional investigation
Store and retrieve DSCSA documentation when requested

For many pharmacies, this adds new responsibility to an already busy workflow. Without the right system in place, DSCSA compliance can slow down receiving, increase manual work, and create risk if documentation is missing or incomplete.

Do Small Dispensers Have More Time to Comply?

Some small dispensers have additional time to comply with certain enhanced DSCSA requirements. FDA issued exemptions for small dispensers until November 27, 2026. A small dispenser is generally defined as a pharmacy dispenser whose corporate entity has 25 or fewer full-time employees licensed as pharmacists or qualified as pharmacy technicians as of November 27, 2024.

However, this does not mean DSCSA no longer applies. The exemption only applies to certain enhanced drug distribution security requirements. Small dispensers are still expected to meet other DSCSA obligations and continue making progress toward full compliance. FDA’s exemption notice states that the exemptions do not apply to all other DSCSA requirements.

For example, pharmacies may still need to:

Receive and maintain transaction information and transaction statements
Know where DSCSA records are stored and how to access them
Work only with authorized trading partners
Have procedures to identify, investigate, and handle suspect or illegitimate products
Show progress toward full electronic DSCSA compliance when requested by regulators, suppliers, or other stakeholders

The key point is simple: the small dispenser exemption gives certain pharmacies more time for specific electronic, interoperable requirements — it does not remove the need to prepare for DSCSA compliance.

Why Does a Pharmacy Need a DSCSA Solution Provider?

Technically, a pharmacy can try to manage DSCSA compliance on its own. However, doing it manually can quickly become time-consuming, difficult to manage, and more expensive in the long run.

Pharmacies need to think through several important questions:

Who will oversee DSCSA compliance on a daily basis?
How will the pharmacy receive transaction data electronically?
How will staff review and match transaction data to the products received?
What system will store DSCSA records, and how quickly can those records be retrieved?
Who will handle product tracing or product verification requests?
How will the pharmacy manage documentation from every supplier it purchases from?
If using supplier portals, who will log into each portal every time product data needs to be found, reviewed, or retrieved?

For pharmacies that purchase from multiple suppliers, relying on separate wholesaler or supplier portals can become inefficient. Staff may need to log into different systems, search for transaction data, download records, and manually match information to the products received.

A DSCSA solution provider helps centralize and simplify this process. Instead of managing compliance across scattered portals, paper records, spreadsheets, or manual workflows, pharmacies can use one system to manage traceability, verification, documentation, and retrieval.

This helps reduce manual work, improve organization, and make DSCSA compliance easier to manage as part of the pharmacy’s daily workflow.

Why Should Pharmacies Prepare Now?

Some pharmacies may think they can wait until closer to November 27, 2026, but DSCSA compliance is not something that can be handled overnight.

The FDA and industry regulators expect pharmacies to continue making progress. The stabilization period and the small dispenser exemption were not intended to pause compliance efforts. They were designed to give the industry more time to move toward full compliance without disrupting the flow of prescription drugs to patients.

Pharmacies may still be asked by Boards of Pharmacy, PBMs, DEA, suppliers, auditors, or other regulatory bodies to show that they have a DSCSA plan in place and are taking steps toward compliance.

Implementing a DSCSA solution takes time. Pharmacies may need time to:

Connect with suppliers
Set up electronic data exchange
Train staff
Create internal policies and procedures
Test receiving and documentation workflows
Prepare for product tracing, verification, and audit requests

Supplier connections can also take time. Some suppliers may have waitlists before they can begin the connection process, and each setup may take additional time to complete.

That is why waiting until the deadline can create unnecessary stress and risk. Pharmacies that start earlier have more time to build the right process, train their team, and avoid last-minute compliance issues.

InfiniTrak helps pharmacies move toward DSCSA compliance with a secure, reliable platform built to enable drug traceability, supplier connections, product verification, documentation, and daily compliance workflows.